Compare Cassava Sciences Inc (FLNA) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Energy Select Sector SPDR Fund — how do they compare? Cassava Sciences Inc trades at $0.83 (market cap $39.40M), while Energy Select Sector SPDR Fund trades at $65.68 (market cap $40.84B). The key difference: Energy Select Sector SPDR Fund is far larger — about 1036.5× Cassava Sciences Inc's market cap, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| FLNA | XLE | |
|---|---|---|
Market Cap | $39.40M | $40.84B |
Volume | 759,018 | 50,409,268 |
Sector | Health | — |
52-Week High | $4.64 | $65.93 |
52-Week Low | $0.68 | $42.61 |
Typical Hold Time | 37 Days | 67 Days |
Enterprise Value | -$43.28M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Filana Therapeutics (FLNA) trades at $0.82, down 6.77% today, amid bearish technical signals but with positive fundamental catalysts. The company shows improving quarterly EPS beats and a favorable EV/EBITDA of 1.03, though it remains unprofitable with negative cash flow. Recent FDA clearance for its epilepsy drug trial has generated optimism, reflected in strong analyst buy ratings (67% consensus).
The outlook balances clinical progress against financial strain. The FDA hold lift on simufilam provides a clear near-term catalyst for Phase 2a trials starting in 2027, supporting the bullish analyst view. However, high cash burn (-$33M net CF in 2025) and lack of revenue pose significant risks to sustainability, requiring careful monitoring of funding and trial milestones.
XLE (Energy Select Sector SPDR ETF) trades at $65.46, up 3.28% with strong bullish momentum from moving averages but overbought RSI signals. The ETF faces mixed sentiment as oil prices surge above $100 amid Middle East tensions while futures traders bet on a 12% energy sector decline. Recent news highlights strategic oil reserve concerns and diesel price pressures, creating volatility in energy markets.
Outlook remains volatile with geopolitical risks and Fed policy influencing energy prices. The ETF's 91% oil and gas concentration offers pure energy exposure but amplifies crude price sensitivity. Key risks include oil price reversals and export restrictions, while institutional flows into midstream ETFs suggest defensive positioning within the sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
